Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD.

Slides:

Advertisements

Similar presentations

FDA Medical Device Update

Advertisements

Personal Finance Product Labels. Food Products Required Information by the FDA Common name Form of food (whole, chopped, diced, etc) Net weight or volume.

Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.

ALERT: The Basics Food and Drug Administration Center for Food Safety and Applied Nutrition.

Kentucky Administrative Review Training. Reinvention Goals The Healthy, Hunger-Free Kids Act of 2010 calls for a more effective and efficient review process:

© 2008 RightNow Technologies, Inc. RightNow Feedback Overview & Demo Andrew Hull Director Product Marketing.

MFRPS Lesson Learned North Carolina

What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.

Medication Reconciliation Insert your hospital’s name here.

Bibliographic Instruction Presentation (LIS 5916) U.S. Food and Drug Administration (FDA) By George Nichols (June 2005)

FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.

SEMINAR NAIC/ASSAL/SVS REGULATION & SUPERVISION OF MARKET CONDUCT © 2014 National Association of Insurance Commissioners Complaint Handling.

Why Are They Important?. Why are competencies important? How do you show senior execs what’s been accomplished? In systems terms Learning is an expensive.

External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.

Early Childhood Information Sharing Toolkit for Community Providers June 2009.

FDA’s MedWatch Program Outreach to Healthcare Professionals and the Public n Managing the Risks of Medical Product Use.

SAFE Safe Animal Feed Education Program 2003 California Department of Food & Agriculture Agricultural Commodities & Regulatory Services Branch.

FDA MedWatch and Patient Safety. Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006  The Act defines a ‘serious adverse event’

Preventive Controls Phase 2 Workgroup 1.

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

The Changing Food Environment The Role and Activities of the U.S. Food and Drug Administration Transatlantic Consumer Dialogue The Changing Food Environment.

Christian Asher.  there are more than 50,000 Dietary supplements available on the market today.  Dietary supplements are more popular than they’ve ever.

Dietary Supplements Bradford W. Williams Special Assistant Division of Dietary Supplement Programs ONPLDS, CFSAN, FDA.

POSTMARKETING ADVERSE DRUG EXPERIENCE INSPECTIONAL PROGRAM CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.

Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 

Council for Responsible Nutrition Supplyside West, October 19, 2006 The Case for Mandatory Reporting of Adverse Events for Dietary Supplements Steve Mister.

October 18,  Benefit Year Earnings (BYE): Root Causes Identified:  Agency Causes  Insufficient resources  Claimant Causes  Unreported/Under.

Top 10 Medical Device Citations

1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.

MATTHEW MATKOVICH MINE EQUIPMENT COMPLIANCE SPECIALIST QUALITY ASSURANCE & MATERIALS TESTING DIVISION MSHA – APPROVAL & CERTIFICATION CENTER 30CFR, PART.

NN/LM National Initiatives Pacific Southwest Region May 15 th, 2013 Midday at the Oasis.

Life Sciences Research Office (LSRO) Evaluating Adverse Event Reporting Systems for Dietary Supplements January 30-31, 2003 “Open Portion of Meeting”

OB Adverse Events Affinity Group March 27, 2013 Lynne Hall.

Regulation and Labeling Food Technology Ch 26. Regulation and Labeling The Food and Drug Administration (FDA) and the United States Dept of Agriculture.

The OSH Act, Standards, & Liabilities

Patricia W. Potrzebowski, Ph.D. Executive Director National Association for Public Health Statistics and Information Systems January 25, 2012 Vital Statistics.

Bibliography Amoore, J., Ingram, P. (2002, August). Quality improvement report: Learning from adverse incidents involving medical devices. British Medical.

October 14,  Benefit Year Earnings (BYE): Root Causes Identified:  Agency Causes  Failure to properly investigate earnings in a timely manner.

ESRD Network 6 5 Diamond Patient Safety Program Medication Reconciliation 2009.

Defining Dietary Supplements Provided Courtesy of RD411.com Where dietitians go for information Review Date 11/11 G-0519.

July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.

Nutrition Facts Food Labels

FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,

Postmarketing Pharmacovigilance Practice at FDA Lanh Green, Pharm.D., M.P.H. Office of Surveillance and Epidemiology June 21, 2006.

Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.

FDA/FSIS Food Safety Survey Methods Amy Lando, MPP Consumer Studies Team Office of Scientific Analysis and Support Center for Food Safety and Applied Nutrition.

Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:

HOW TECHNOLOGY WORKS. TECHNOLOGY Using knowledge to develop products and systems that satisfy needs, solve problems, and increase our capabilities.

2016 MFRPS: Changes To Standard 10 Guy F. Delius, R. S. CSO Food and Drug Administration Office Of Partnerships Standards Implementation Staff February.

Department of Defense Voluntary Protection Programs Center of Excellence Development, Validation, Implementation and Enhancement for a Voluntary Protection.

CPSC Data Bases Tom Schroeder 3/11 *This presentation was prepared by CPSC staff. It has not been reviewed or approved by, and may not necessarily reflect.

FDA Notifications and Medwatch Form Requirements Adverse Event Reporting for OTC Drugs and Dietary Supplements.

Nutritional Supplements An Issue Everyone Needs to Know.

Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.

Center for Food Safety & Applied Nutrition: Update

FHIR Adverse Event Resource

Graduate Faculty Appointment Request Form

NAME:NASHTE AJAYKUMAR KALYAN

Dietary Supplements: What you should know

Overview of FDA Food Inspections

Risk Management Case Study: The RADARS® System

Department | Website | Phone Number

Patient Involvement in the Development and Safe Use of

FDA Regulated Special Interest Group

FDA Sentinel Initiative

Name of Event Name of Event Date, location, department

Introduction to the PACS Security

Module 2.1 Facilities Management

Presentation transcript:

Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD

CAERS Why does the FDA need CAERS? What does the FDA want to accomplish?

 Recognized Need for an Improved System  Combined Old Computer Systems  Security  International Adverse Events  Counter Terrorism Tool CAERS WHY is the FDA Developing CAERS?

 Address Serious Adverse Events  Track and Monitor Adverse Events  Analyze for Trends (Consumer Complaints)  Speed the Time of Review WHAT Does the FDA Want to Accomplish with CAERS?

What is an Adverse Event? An illness or injury to an individual alleged to be caused by the use of a product. MINIMUM DATA NEEDED – Adverse event – Manufacturer – Injured Person – Report date – CFSAN Product

What Is Redacted from Adverse Event Reports?  All identifying information of Non-FDA people and places Names and addresses Where consumer purchased product  Medical Records Insurance Information Autopsy Numbers Signatures / Initials Date of Birth

What is not Redacted?  Names of Members of Congress  Gender  Age  Date of Death  Manufacturers  FDA tracking numbers  Symptom

A PASSIVE VS. An ACTIVE SYSTEM CAERS CAERS is Passive but all Inclusive 7000 Voluntary Adverse Events and Consumer Complaints Mandatory Adverse Event Reporting?

 Daily Downloads (FDA Field and Follow-up)  Phone Calls, 800#s, and Letters  AERS Drug links HOW Does CAERS Work?

Field Accomplishments and Compliance Tracking System (FACTS)  Industry Codes 54 Dietary Supplements 53 Cosmetics 40 Infant and Junior Food Product

 Computer Design Requirements  New Document Management System  Pilot Operations Ongoing  Training  Searching capabilities WHAT Have We Done So Far with CAERS?

Firm Letter Notification (FY-2003)  Informational/Transparency (share knowledge)  Sent to manufacturer address on report or as designated  Only illness or injury  FDA verification and validation (Fraud)  Redacted for personal identifiers  Ask for other industry reports  Disclaimer

Limited Resources Not Consumer Friendly Limited Fields/Trends Lack of Accurate Information Hard to Search Updating Problems Concentrate on CAERS CAERS Remove the Dietary Supplement Adverse Event Website? Why Did CAERS Remove the Dietary Supplement Adverse Event Website?

 Invite Industry and Consumer Input  Looking for the best information that is useful and meaningful  Case #/firm/product/ingredient/symptom  Cause and effect / FDA opinion? The New CAERS Website

WHAT’S in CAERS’ FUTURE?  FY-2003 Go Operational by June 2003 Receive FDA field downloads  FY-2004 Build links to Drug AERS Build links to MedWatch  FY-2005Complete legacy data transfer Build a link to Poison Control  FY-2006 Build Thesauri for Ingredients, Products and Botanicals